PMC:2700745 / 51009-51462 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/2700745","sourcedb":"PMC","sourceid":"2700745","source_url":"https://www.ncbi.nlm.nih.gov/pmc/2700745","text":"Cyclophosphamide treatment has been used to immunosuppress mice to assess the efficacy of a neuraminidase inhibitor (peramivir) in an immunocompromised host (Sidwell et al., 2003). Cyclophosphamide was injected intraperitoneally at a dose of 100 mg/kg every 4 days for varying lengths of time. Peramivir was capable of significantly ameliorating the influenza virus infection in mice immunosuppressed by short-term or prolonged cyclophosphamide therapy.","tracks":[{"project":"2_test","denotations":[{"id":"19176218-14516917-100518407","span":{"begin":174,"end":178},"obj":"14516917"},{"id":"19176218-14516917-100518407","span":{"begin":174,"end":178},"obj":"14516917"},{"id":"19176218-14516917-3579343","span":{"begin":174,"end":178},"obj":"14516917"},{"id":"19176218-14516917-3579343","span":{"begin":174,"end":178},"obj":"14516917"}],"attributes":[{"subj":"19176218-14516917-100518407","pred":"source","obj":"2_test"},{"subj":"19176218-14516917-100518407","pred":"source","obj":"2_test"},{"subj":"19176218-14516917-3579343","pred":"source","obj":"2_test"},{"subj":"19176218-14516917-3579343","pred":"source","obj":"2_test"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"2_test","color":"#aaec93","default":true}]}]}}